R) for Schizophrenia Treatment

The U.S. Food and Drug Administration approved a 12.5 mg dose of RISPERDAL® CONSTA® [ Long-Acting Injection ] for the treatment of schizophrenia within specific patient populations, including those with renal and hepatic impairment.
From: biz.yahoo.com